The public health control of scabies: priorities for research and action

Daniel Engelman; Paul T. Cantey; Michael Marks; Anthony W. Solomon; Aileen Y. Chang; Olivier Chosidow; Wendemagegn Enbiale; Dirk Engels; Roderick J. Hay; D. Hendrickx; Peter J. Hotez; John M. Kaldor; Mike Kama; Charles D. Mackenzie; James S. McCarthy; Diana L. Martin; Birhan Mengistu; Toby Maurer; Nebiyu Negussu; L. Romani; Oliver Sokana; Margot J. Whitfeld; L. Claire Fuller; Andrew C. Steer

doi:10.1016/S0140-6736(19)31136-5

The public health control of scabies: priorities for research and action

Daniel Engelman, Paul T. Cantey, Michael Marks, Anthony W. Solomon, Aileen Y. Chang, Olivier Chosidow, Wendemagegn Enbiale, Dirk Engels, Roderick J. Hay, D. Hendrickx, Peter J. Hotez, John M. Kaldor, Mike Kama, Charles D. Mackenzie, James S. McCarthy, Diana L. Martin, Birhan Mengistu, Toby Maurer, Nebiyu Negussu, L. RomaniOliver Sokana, Margot J. Whitfeld, L. Claire Fuller, Andrew C. Steer

Telethon Kids Institute

Research output: Contribution to journal › Review article

17 Citations (Scopus)

Abstract

Scabies is a parasitic disease of the skin that disproportionately affects disadvantaged populations. The disease causes considerable morbidity and leads to severe bacterial infection and immune-mediated disease. Scientific advances from the past 5 years suggest that scabies is amenable to population-level control, particularly through mass drug administration. In recognition of these issues, WHO added scabies to the list of neglected tropical diseases in 2017. To develop a global control programme, key operational research questions must now be addressed. Standardised approaches to diagnosis and methods for mapping are required to further understand the burden of disease. The safety of treatments for young children, including with ivermectin and moxidectin, should be investigated. Studies are needed to inform optimum implementation of mass treatment, including the threshold for intervention, target, dosing, and frequency. Frameworks for surveillance, monitoring, and evaluation of control strategies are also necessary.

Original language	English
Pages (from-to)	81-92
Number of pages	12
Journal	The Lancet
Volume	394
Issue number	10192
DOIs	https://doi.org/10.1016/S0140-6736(19)31136-5
Publication status	Published - 6 Jul 2019

Access to Document

10.1016/S0140-6736(19)31136-5

Fingerprint Dive into the research topics of 'The public health control of scabies: priorities for research and action'. Together they form a unique fingerprint.

Cite this

Engelman, D., Cantey, P. T., Marks, M., Solomon, A. W., Chang, A. Y., Chosidow, O., Enbiale, W., Engels, D., Hay, R. J., Hendrickx, D., Hotez, P. J., Kaldor, J. M., Kama, M., Mackenzie, C. D., McCarthy, J. S., Martin, D. L., Mengistu, B., Maurer, T., Negussu, N., ... Steer, A. C. (2019). The public health control of scabies: priorities for research and action. The Lancet, 394(10192), 81-92. https://doi.org/10.1016/S0140-6736(19)31136-5

Engelman, Daniel ; Cantey, Paul T. ; Marks, Michael ; Solomon, Anthony W. ; Chang, Aileen Y. ; Chosidow, Olivier ; Enbiale, Wendemagegn ; Engels, Dirk ; Hay, Roderick J. ; Hendrickx, D. ; Hotez, Peter J. ; Kaldor, John M. ; Kama, Mike ; Mackenzie, Charles D. ; McCarthy, James S. ; Martin, Diana L. ; Mengistu, Birhan ; Maurer, Toby ; Negussu, Nebiyu ; Romani, L. ; Sokana, Oliver ; Whitfeld, Margot J. ; Fuller, L. Claire ; Steer, Andrew C. / The public health control of scabies : priorities for research and action. In: The Lancet. 2019 ; Vol. 394, No. 10192. pp. 81-92.

@article{38dab76d7c1545a58fcaa23246691b41,

title = "The public health control of scabies: priorities for research and action",

abstract = "Scabies is a parasitic disease of the skin that disproportionately affects disadvantaged populations. The disease causes considerable morbidity and leads to severe bacterial infection and immune-mediated disease. Scientific advances from the past 5 years suggest that scabies is amenable to population-level control, particularly through mass drug administration. In recognition of these issues, WHO added scabies to the list of neglected tropical diseases in 2017. To develop a global control programme, key operational research questions must now be addressed. Standardised approaches to diagnosis and methods for mapping are required to further understand the burden of disease. The safety of treatments for young children, including with ivermectin and moxidectin, should be investigated. Studies are needed to inform optimum implementation of mass treatment, including the threshold for intervention, target, dosing, and frequency. Frameworks for surveillance, monitoring, and evaluation of control strategies are also necessary.",

author = "Daniel Engelman and Cantey, {Paul T.} and Michael Marks and Solomon, {Anthony W.} and Chang, {Aileen Y.} and Olivier Chosidow and Wendemagegn Enbiale and Dirk Engels and Hay, {Roderick J.} and D. Hendrickx and Hotez, {Peter J.} and Kaldor, {John M.} and Mike Kama and Mackenzie, {Charles D.} and McCarthy, {James S.} and Martin, {Diana L.} and Birhan Mengistu and Toby Maurer and Nebiyu Negussu and L. Romani and Oliver Sokana and Whitfeld, {Margot J.} and Fuller, {L. Claire} and Steer, {Andrew C.}",

year = "2019",

month = jul,

day = "6",

doi = "10.1016/S0140-6736(19)31136-5",

language = "English",

volume = "394",

pages = "81--92",

journal = "Lancet",

issn = "0140-6736",

publisher = "Academic Press",

number = "10192",

}

Engelman, D, Cantey, PT, Marks, M, Solomon, AW, Chang, AY, Chosidow, O, Enbiale, W, Engels, D, Hay, RJ, Hendrickx, D, Hotez, PJ, Kaldor, JM, Kama, M, Mackenzie, CD, McCarthy, JS, Martin, DL, Mengistu, B, Maurer, T, Negussu, N, Romani, L, Sokana, O, Whitfeld, MJ, Fuller, LC & Steer, AC 2019, 'The public health control of scabies: priorities for research and action', The Lancet, vol. 394, no. 10192, pp. 81-92. https://doi.org/10.1016/S0140-6736(19)31136-5

The public health control of scabies : priorities for research and action. / Engelman, Daniel; Cantey, Paul T.; Marks, Michael; Solomon, Anthony W.; Chang, Aileen Y.; Chosidow, Olivier; Enbiale, Wendemagegn; Engels, Dirk; Hay, Roderick J.; Hendrickx, D.; Hotez, Peter J.; Kaldor, John M.; Kama, Mike; Mackenzie, Charles D.; McCarthy, James S.; Martin, Diana L.; Mengistu, Birhan; Maurer, Toby; Negussu, Nebiyu; Romani, L.; Sokana, Oliver; Whitfeld, Margot J.; Fuller, L. Claire; Steer, Andrew C.

In: The Lancet, Vol. 394, No. 10192, 06.07.2019, p. 81-92.

Research output: Contribution to journal › Review article

TY - JOUR

T1 - The public health control of scabies

T2 - priorities for research and action

AU - Engelman, Daniel

AU - Cantey, Paul T.

AU - Marks, Michael

AU - Solomon, Anthony W.

AU - Chang, Aileen Y.

AU - Chosidow, Olivier

AU - Enbiale, Wendemagegn

AU - Engels, Dirk

AU - Hay, Roderick J.

AU - Hendrickx, D.

AU - Hotez, Peter J.

AU - Kaldor, John M.

AU - Kama, Mike

AU - Mackenzie, Charles D.

AU - McCarthy, James S.

AU - Martin, Diana L.

AU - Mengistu, Birhan

AU - Maurer, Toby

AU - Negussu, Nebiyu

AU - Romani, L.

AU - Sokana, Oliver

AU - Whitfeld, Margot J.

AU - Fuller, L. Claire

AU - Steer, Andrew C.

PY - 2019/7/6

Y1 - 2019/7/6

N2 - Scabies is a parasitic disease of the skin that disproportionately affects disadvantaged populations. The disease causes considerable morbidity and leads to severe bacterial infection and immune-mediated disease. Scientific advances from the past 5 years suggest that scabies is amenable to population-level control, particularly through mass drug administration. In recognition of these issues, WHO added scabies to the list of neglected tropical diseases in 2017. To develop a global control programme, key operational research questions must now be addressed. Standardised approaches to diagnosis and methods for mapping are required to further understand the burden of disease. The safety of treatments for young children, including with ivermectin and moxidectin, should be investigated. Studies are needed to inform optimum implementation of mass treatment, including the threshold for intervention, target, dosing, and frequency. Frameworks for surveillance, monitoring, and evaluation of control strategies are also necessary.

AB - Scabies is a parasitic disease of the skin that disproportionately affects disadvantaged populations. The disease causes considerable morbidity and leads to severe bacterial infection and immune-mediated disease. Scientific advances from the past 5 years suggest that scabies is amenable to population-level control, particularly through mass drug administration. In recognition of these issues, WHO added scabies to the list of neglected tropical diseases in 2017. To develop a global control programme, key operational research questions must now be addressed. Standardised approaches to diagnosis and methods for mapping are required to further understand the burden of disease. The safety of treatments for young children, including with ivermectin and moxidectin, should be investigated. Studies are needed to inform optimum implementation of mass treatment, including the threshold for intervention, target, dosing, and frequency. Frameworks for surveillance, monitoring, and evaluation of control strategies are also necessary.

UR - http://www.scopus.com/inward/record.url?scp=85068253326&partnerID=8YFLogxK

U2 - 10.1016/S0140-6736(19)31136-5

DO - 10.1016/S0140-6736(19)31136-5

M3 - Review article

C2 - 31178154

AN - SCOPUS:85068253326

VL - 394

SP - 81

EP - 92

JO - Lancet

JF - Lancet

SN - 0140-6736

IS - 10192

ER -